Valganciclovir Hydrochloride For Solution
Product Images NDC 70069-810
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 70069-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Figure 1)
Figure-10 (Figure 10)
Figure-11 (Figure 11)
Figure-12 (Figure 12)
Figure-13 (Figure 13)
Figure-14 (Figure 14)
Figure-2 (Figure 2)
Figure-3 (Figure 3)
Figure-4 (Figure 4)
Figure-5 (Figure 5)
Figure-6 (Figure 6)
Figure-7 (Figure 7)
Figure-8 (Figure 8)
Figure-9 (Figure 9)
Valganciclovir-label1-jpg (Valganciclovir Label1 Jpg)
This is a description of a prescription drug called Valganciclovir Hydrochloride. It is administered orally as a solution, and each mL (milliliter) contains 50mg of valganciclovir. The drug is only available with a prescription. The solution has to be prepared by a pharmacist at the time of dispensing by measuring the dry powder. The dry powder should be stored in a dry place with a temperature range between 20° to 25°C (68" to 77°F), while the solution should be refrigerated between 2°C to 8°C (36° to 46°F). This text does not provide any specific indications regarding the use or effects of the drug.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.